Gaziano, J., Brotons, C., Coppolecchia, R., Cricelli, C., Darius, H., Gorelick, P., . . . Committee, A. (2018). Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): A randomised, double-blind, placebo-controlled trial. Elsevier.
Chicago Style (17th ed.) CitationGaziano, J., et al. Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE): A Randomised, Double-blind, Placebo-controlled Trial. Elsevier, 2018.
MLA引文Gaziano, J., et al. Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE): A Randomised, Double-blind, Placebo-controlled Trial. Elsevier, 2018.